Two papers reported that melanoma patients had greater PD-L1+ circulating T-cell levels than healthy volunteers, and PD-L1+ CD8+ T-cells were raised in disease relapsed or disease-related dead patients (82, 83). Here, CD274 is linked to melanoma.